GenSight Biologics S.A. GSGTF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -17.90M | -15.88M | -13.53M | -14.93M | -16.45M |
| Total Depreciation and Amortization | 582.10K | 559.90K | 529.90K | 618.40K | 714.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.64M | 2.64M | 1.63M | 1.12M | 616.60K |
| Change in Net Operating Assets | 4.03M | 2.54M | 853.50K | 3.60M | 6.37M |
| Cash from Operations | -9.64M | -10.13M | -10.52M | -9.59M | -8.74M |
| Capital Expenditure | -81.60K | -43.20K | -4.60K | -2.30K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 274.00K | 245.10K | 218.40K | 83.20K | -52.60K |
| Cash from Investing | 192.50K | 201.90K | 213.80K | 80.90K | -52.60K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.08M | -1.17M | -1.25M | -2.05M | -2.84M |
| Issuance of Common Stock | 6.38M | 6.28M | 6.18M | 5.96M | 5.74M |
| Repurchase of Common Stock | -8.00K | -4.00K | -- | -2.50K | -5.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 4.32M | 4.17M | 4.02M | 1.42M | -1.18M |
| Cash from Financing | 11.22M | 10.82M | 10.40M | 6.13M | 1.86M |
| Foreign Exchange rate Adjustments | -136.50K | -65.70K | 5.20K | -151.40K | -312.90K |
| Miscellaneous Cash Flow Adjustments | 1.20K | 600.00 | 100.00 | 0.00 | 0.00 |
| Net Change in Cash | 1.64M | 823.90K | 104.20K | -3.53M | -7.25M |